Helping MedTech Startups Prepare for Hospital Adoption MDM2 is developing a virtual Mock Value Analysis Committee to help early-stage Arizona MedTech companies better understand those expectations before they enter a real hospital review process. The initiative will give startups a structured, lower-risk environment to present their technology, answer challenging questions, identify gaps, and strengthen their value proposition. A promising medical technology can show clear pa

Interested in Mock Value Analysis? Join us at Venture Cafe Phoenix on August 20 for a preview: https://venturecafephoenix.org/programs/thursday-gathering/ A promising medical technology can demonstrate a clear patient benefit and still encounter significant obstacles when it reaches a hospital. That’s because hospital adoption decisions rarely depend on clinical value alone. Hospitals also have to consider safety, workflow, training, reimbursement, cost, infrastructure, maint

Understanding Arizona’s Angel Tax Credit Arizona’s Angel Tax Credit is designed to encourage investment in early-stage companies by offering eligible investors a state tax credit for qualified investments. For startups, the program can be a valuable tool for attracting angel capital, reducing perceived investor risk, and helping companies reach important commercialization milestones. For Arizona’s medtech ecosystem, programs like this matter because early-stage companies ofte

Raising early-stage capital is hard in any sector. For medtech, bioscience, weartech, and other regulated or research-intensive startups, it can be even harder. Founders often need meaningful capital before revenue is predictable, while investors need confidence that the risk is worth taking. However, Arizona has a state-level incentive designed to help bridge that gap. The Arizona Angel Tax Credit, formally known as the Arizona Commerce Authority’s Small Business Capital Inv

Arizona’s medtech ecosystem continues to gain momentum, and that progress was on full display during the recent PEI/MDM2 WearTech Demo Day and Angel Tax Credit Discussion at the WearTech Applied Research Center. The event brought together founders, investors, entrepreneurs, healthcare leaders, and ecosystem partners for an afternoon focused on two important themes: the next generation of wearable health technologies and the funding pathways that can help early-stage companies

A Letter from Stu Broyles, Regional Innovation Officer I am honored to step into the role of Regional Innovation Officer and help lead the next chapter of growth for MDM2 and Arizona’s medtech ecosystem. MDM2 has already built a strong foundation for collaboration among industry, healthcare systems, researchers, educators, and innovators, and I am excited to build on that momentum with our consortium partners. I come to this role with more than 20 years of experience in medte

Arizona has no shortage of MedTech ambition. We have smart founders, credible research, and a growing pipeline of startups working on meaningful problems. But even the best ideas can hit a wall early for one simple reason: it is hard to get in front of clinicians in a structured way, early enough, and often enough to shape product development while it still matters. On January 29, 2026, MDM2 took a major step toward solving that challenge by launching its first CME-accredited

Sarah Stabenfeldt is trained in biomedical engineering. She earned her undergraduate degree from Saint Louis University with a focus on biomaterials, followed by a PhD in Bioengineering from Georgia Tech, where she specialized in polymer based material systems for neurotrauma. She then completed an NIH funded postdoctoral fellowship jointly administered by Georgia Tech, Emory University, and Morehouse College, This program integrated advanced research with formal pedagogic

MDM2 and SEMI are committed to accelerating innovation at the intersection of semiconductors and MedTech. Arizona’s latest smart MedTech conference is just one of the latest ways we are supporting the MedTech community.